Rich Johnson is a co-founder of Saros Therapeutics and as VP of Development, he leads all aspects of the development planning and execution. Rich has 28 years of experience leading biopharma R&D groups from discovery to preclinical development. He earned a PhD from Duquesne University in protein biochemistry and trained in immunology during his post-doctoral fellowship in the Pathology Department at UCSD.